Modified HFNC Oxygen in Patients Undergoing Bronchoscopy.
Modified High-flow Nasal Cannula Oxygen in Patients Undergoing Bronchoscopy.
1 other identifier
interventional
812
1 country
1
Brief Summary
The purpose of this study is to determine whether the Modified High-flow nasal cannula is effective in the oxygen of the patients undergoing bronchoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 14, 2015
CompletedFirst Posted
Study publicly available on registry
November 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedAugust 19, 2020
August 1, 2020
4.1 years
November 14, 2015
August 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the proportion of patients SpO2 < 90% during bronchoscopy
1 hour
Secondary Outcomes (1)
the operation time
1 hour
Study Arms (2)
Modified High-flow nasal cannula therapy
ACTIVE COMPARATORPatients undergoing bronchoscopy are given Modified High-flow nasal cannula oxygen therapy all the time.
Nasal cnnnula therapy
ACTIVE COMPARATORPatients undergoing bronchoscopy are given nasal cannula oxygen therapy all the time.
Interventions
Modified High-flow nasal cannula
Eligibility Criteria
You may qualify if:
- age more than 18 years old;
- need for bronchoscopy for diagnosis purpose.
You may not qualify if:
- peripheral arterial pulse oximetry was \< 90%
- platelet count \< 60 × 109/L;
- nasopharyngeal obstruction or blockage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Haichao Lilead
Study Sites (1)
Department of respiratory and critical care medicine,Beijing Chaoyang Hospital
Beijing, Beijing Municipality, 100020, China
Related Publications (3)
Lucangelo U, Vassallo FG, Marras E, Ferluga M, Beziza E, Comuzzi L, Berlot G, Zin WA. High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy. Crit Care Res Pract. 2012;2012:506382. doi: 10.1155/2012/506382. Epub 2012 May 20.
PMID: 22666567RESULTDiab S, Fraser JF. Maintaining Oxygenation Successfully with High Flow Nasal Cannula during Diagnostic Bronchoscopy on a Postoperative Lung Transplant Patient in the Intensive Care. Case Rep Crit Care. 2014;2014:198262. doi: 10.1155/2014/198262. Epub 2014 Nov 13.
PMID: 25478241RESULTWang R, Li HC, Li XY, Tang X, Chu HW, Yuan X, Tong ZH, Sun B. Modified high-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients undergoing bronchoscopy: a randomized clinical trial. BMC Pulm Med. 2021 Nov 14;21(1):367. doi: 10.1186/s12890-021-01744-8.
PMID: 34775948DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bing Sun, MD
Beijing Chao Yang Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor-Investigator
Study Record Dates
First Submitted
November 14, 2015
First Posted
November 17, 2015
Study Start
November 1, 2015
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
August 19, 2020
Record last verified: 2020-08